ASHENEWS reports that renowned global biopharmaceutical company, AstraZeneca has announced plans to invest 1.5 billion dollars in building a manufacturing facility in Singapore for antibody-drug conjugates (ADCs).
Trending
- Smart Farming: SAA-KNARDA-KSADP Model for Food Security in Nigeria, Prof M. K. Othman
- Kwara govt laments low breastfeeding rate among nursing mothers
- UNICEF says 95m Nigerians lack access to sanitation services
- NIHORT to register, release new pepper varieties soon – Official
- Plugging methane leaks in Nigeria equals removing 400,000 cars, says UNEP
- Inclusive policies critical for Africa’s renewable energy future, experts say
- Google introduces advanced theft protection features for android devices
- Health sector stakeholders meet in Maiduguri to accelerate pathways to UHC
